ロード中...
High-throughput flow cytometry (HTFC) drug combination discovery with novel synergy analysis software, SynScreen
Classical therapeutic regimens are subject to toxicity, low efficacy, and/or the development of drug resistance. Thus, the discovery of synergistic drug combinations would permit treatment with lower, tolerable dosages of each agent and restored sensitivity. We describe the development and use of th...
保存先:
| 出版年: | SLAS Discov |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6363001/ https://ncbi.nlm.nih.gov/pubmed/29842834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2472555218775913 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|